Peptidoglycan preparation from Bifidobacterium longum CCM 7952 mitigates allergic airway inflammation in a MyD88-dependent manner

Abstract Intranasal administration of heat-inactivated Bifidobacterium longum CCM7952 (Bl7952) alleviates allergic airway inflammation (AAI); however, the specific cell-wall components responsible for this anti-allergic effect, as well as the underlying immunological mechanism, remain unknown. In this study, the anti-allergic and immunomodulatory properties of Bl7952 cell-wall components were investigated in female BALB/c, C57BL/6, NOD2 −/− , and MyD88 −/− mice using a murine model of AAI. Four hours before each allergen (ovalbumin) application, isolated Bl7952 surface components, including slime and cell wall-derived polysaccharides, surface proteins, or a peptidoglycan preparation, were administered intranasally. Among these components, only the peptidoglycan preparation significantly down-regulated the Th2-associated immune response and eosinophil infiltration into the lungs. This effect was largely dependent on MyD88 adapter protein and independent of NOD2 receptor signaling. Furthermore, the Bl7952-derived peptidoglycan preparation altered the frequencies of antigen-presenting and T cells in the lungs of naïve mice. Thus, the peptidoglycan preparation from Bl7952 exerts prophylactic anti-allergic effects, underscoring its potential as an immunomodulator for preventing AAI.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-17
DOI
https://doi.org/10.1038/s41598-026-78815-5
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peptidoglycan preparation from Bifidobacterium longum CCM 7952 mitigates allergic airway inflammation in a MyD88-dependent manner

Umesh Kumar Gautam, Dagmar Šrůtková, Marcelina Joanna Pyclik, Tereza Novotná et al.
Scientific Reports
Asthma and respiratory diseases
article

Peptidoglycan preparation from Bifidobacterium longum CCM 7952 mitigates allergic airway inflammation in a MyD88-dependent manner

Umesh Kumar Gautam, Dagmar Šrůtková, Marcelina Joanna Pyclik, Tereza Novotná, Irma Schabussová, Katarzyna Leszczyńska, Katarzyna Pacyga-Prus, Sudhanshu Shekhar, Aleksandra Inić‐Kanada, Martin Schwarzer, Michael Thaler, Viktor Černý, Tereza Horníková, Barbora Valaskova, Anna Michl, Sabina Gorska
article en

Abstract

Abstract Intranasal administration of heat-inactivated Bifidobacterium longum CCM7952 (Bl7952) alleviates allergic airway inflammation (AAI); however, the specific cell-wall components responsible for this anti-allergic effect, as well as the underlying immunological mechanism, remain unknown. In this study, the anti-allergic and immunomodulatory properties of Bl7952 cell-wall components were investigated in female BALB/c, C57BL/6, NOD2 −/− , and MyD88 −/− mice using a murine model of AAI. Four hours before each allergen (ovalbumin) application, isolated Bl7952 surface components, including slime and cell wall-derived polysaccharides, surface proteins, or a peptidoglycan preparation, were administered intranasally. Among these components, only the peptidoglycan preparation significantly down-regulated the Th2-associated immune response and eosinophil infiltration into the lungs. This effect was largely dependent on MyD88 adapter protein and independent of NOD2 receptor signaling. Furthermore, the Bl7952-derived peptidoglycan preparation altered the frequencies of antigen-presenting and T cells in the lungs of naïve mice. Thus, the peptidoglycan preparation from Bl7952 exerts prophylactic anti-allergic effects, underscoring its potential as an immunomodulator for preventing AAI.

Scientific Reports
Charles University (CZ), Czech Academy of Sciences, Institute of Microbiology (CZ), General University Hospital in Prague (CZ), Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL), Medical University of Vienna (AT), Polish Academy of Sciences (PL)
Grantová Agentura České Republiky, Austrian Science Fund, OeAD-GmbH
Good health and well-being
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon